Champion Sponsor
Walgreens offers comprehensive expertise, services, and products to support people living with or at risk of diabetes. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving nearly 10 million customers each day. Walgreens is committed to helping the diabetes community start and maintain an optimal regimen and routine to live a healthy life as a trusted member of their healthcare team, offering enhanced services focused on expanding access to affordable, local care. The company invests in special training to equip pharmacists with expert knowledge about medications, continuous glucose monitors, nutrition, how to keep A1C and blood glucose levels on target, and more. To best meet the needs of all customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in communities nationwide.
Diamond Level Sponsor
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Platinum Level Sponsor
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.
Gold Level Sponsors
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
We’re a medicine company turning science into healing to make life better for people around the world.
Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world’s most significant health challenges. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: “Take what you find here and make it better and better.”
But we’re not only dedicated to making medicines. We go beyond medicine to deliver innovative clinical trials that reflect the diversity of our world and work to ensure our medicines are accessible and affordable. Learn more at www.lilly.com/who-we-are/about-lilly.
Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced technology and always-on support when and how it is needed. Medtronic has pioneered first-of-its-kind innovations for over 40 years and is committed to designing the future of diabetes management through next-generation sensors (CGM), intelligent dosing systems, and the power of data science and AI while always putting the customer experience at the forefront. Today we offer the MiniMed™ 780G insulin pump system, the InPen™ smart insulin pen and the i-Port Advance™ injection port, and we continue to innovate further. With a renewed focus on creating products that are easy to use, we hope our future technologies will enable people to focus more on life, and not diabetes. To learn more, visit www.medtronicdiabetes.com and follow us on Facebook, Instagram, TikTok, YouTube and LinkedIn.
Tandem Diabetes Care creates new possibilities for people living with diabetes, their loved ones, and their healthcare providers through a positively different experience. We deliver innovative products and automated insulin delivery systems — including Tandem Mobi and the t:slim X2 — to people who require insulin therapy. For more information, visit tandemdiabetes.com.
Silver Level Sponsors
Abbott is a global healthcare leader helping people live more fully at all stages of life. Our FreeStyle Libre portfolio has changed the lives of more than 5.5 million people across more than 60 countries because it is simple, effective and affordable. We’re proud to sponsor the Friends for Life Orlando Conference, raising awareness for diabetes technology to help the 352,000 children and adolescents living with the condition in the U.S. today. Connect with us at https://freestyle.abbott/cwd, on Instagram at @FreeStyleDiabetes, and on Facebook at @FreeStyleUS.
Sequel is dedicated to developing next-generation drug-delivery advancements, starting with its FDA-cleared device, the twiist™ Automated Insulin Delivery (AID) system powered by Tidepool. The twiist system integrates innovative technologies to reimagine insulin delivery and sets a new standard for diabetes management providing simplified access and personalized control for PWD.
Bronze Level Sponsors
Amphastar Pharmaceuticals, Inc. is a recognized pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products including BAQSIMI® (glucagon) nasal powder 3mg. BAQSIMI is the #1 prescribed glucagon in the US and the first and only dry nasal spray that can treat low blood sugar emergencies. BAQSIMI is different from other low blood sugar treatments because it is a form of glucagon delivered as a puff in the nose instead of as an injection. BAQSIMI is a prescription medicine. For indications and usage and important safety information, please visit www.baqsimi.com.
Breakthrough T1D (formerly JDRF) is the leading global type 1 diabetes (T1D) research and advocacy organization working to accelerate life-changing breakthroughs to cure, prevent, and treat T1D and its complications. We are the same organization, with the same mission and mission statement—just with a new name and look. We are bringing our 50+ year history with us to celebrate our past, present, and future while aligning our brand with who our organization is today. And always, we continue being guided by a single purpose: as we drive toward curing type 1 diabetes, we help make everyday life better for the people who face it. Learn more at BreakthroughT1D.org.
In 1923, the founders of Novo Nordisk began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes. Novo Nordisk is proud to be a Bronze Level Sponsor of the Friends for Life conference. Please come see us at the exhibition to find out more about our company and our products. To learn more about Novo Nordisk and our support to the type 1 diabetes community, visit us at www.novonordisk-us.com.
Xeris Pharmaceuticals, Inc., the maker of Gvoke HypoPen® (glucagon injection), is dedicated to unlocking the potential of glucagon. We believe that our technology can have a profound impact on the lives of patients and their families. That’s why we are proud to be the first to develop liquid glucagon, but that’s just the beginning. We’re also studying how our formulation technology can impact patients with other conditions. We have a persistent drive to pursue solutions that have the potential to change lives. Get to know us and see how our technology is unlocking the potential of today’s medicines at www.xerispharma.com
Friends of CWD
Beta Bionics is a medical technology company focused on the design, development, and commercialization of its iLet Bionic Pancreas in both the single hormone and bi-hormonal configurations. The iLet Bionic Pancreas platform is designed to use adaptive, self-learning, control algorithms, together with continuous glucose monitoring and pump technology, to autonomously compute and administer doses of insulin and/or glucagon and mimic the body’s natural ability to maintain tight glycemic control, relieving some of the burden of living with diabetes. To learn more, visit http://www.betabionics.com.
The Certification Board for Diabetes Care and Education (CBDCE) is a not for profit certifying body that recognizes a number of different health professionals in the United States as having specialized knowledge about diabetes care and education. The organization name and certification designation underwent a change in 2020; you might be more familiar with the National Certification Board for Diabetes Educators or NCBDE and the Certified Diabetes Educator or CDE certification designation. The organization has been around since 1986, and the Certified Diabetes Care and Education Specialist or CDCES credential is seen as the gold standard in the diabetes world. Currently, over 19,900 health professionals hold the CDCES credential. CDCESs are committed and passionate about what the work they do in partnership with people with diabetes and their families and caregivers.
The Diabetes Patient Advocacy Coalition (DPAC) is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of all 37.3 million Americans with diabetes. We train people in the diabetes community on how to be advocates for themselves and their families. We work to ensure quality of and access to care, medications, and devices for patients living with diabetes; and to educate, inspire, and empower patient advocates as well as lawmakers toward meaningful action on diabetes.
Diamyd Medical develops precision medicine therapies for the prevention and treatment of Type 1 Diabetes and LADA (Latent Autoimmune Diabetes in Adults). Diamyd® is an antigen-specific immunotherapy for the preservation of endogenous insulin production that has Orphan Drug Designation in the U.S. and, in February 2024, was granted Fast Track designation by the U.S. FDA. DIAGNODE-3, a confirmatory Phase III trial is actively recruiting patients with recent-onset Type 1 Diabetes in eight European countries and in the US. Significant results have previously been shown in a large genetically predefined patient group – in a large-scale meta-analysis and in the Company’s European Phase IIb trial, where Diamyd® was administered directly into a superficial lymph node in children and young adults with recently diagnosed Type 1 Diabetes.
Level Life specializes in efficient and fast-acting glucose management solutions, specifically designed to assist individuals with diabetes in maintaining optimal blood sugar levels effortlessly and safely. Our cornerstone product, the Level Life Glucose Gels, offers a precisely measured dose of 15 grams of fast-acting glucose that helps manage blood sugar lows quickly and effectively. To learn more, visit levellifebrands.com or follow us on TikTok, Instagram, and Facebook.
CustomTypeOne was founded by Jon Fawcett after his daughter was diagnosed with type 1 at the age of 12. He dove head first into the DIY community and wrote the Loop Follow app as well as customized Loop patches used by thousands of DIY Loopers. These were developed because of his own daughter’s needs and then offered to the community as a way to make living with type 1 easier. After years of being actively involved in the DIY community, CustomTypeOne was founded with the goal of bringing some of the DIY benefits to everyone.
As his daughter grew older and was sleeping through her alerts, he recognized the need for an alert system that would wake a sleepy teenager from the deepest sleep especially knowing that she would soon be an independent adult. With that SugarPixel was created as a secondary alert system with randomized audio and vibration alerts to minimize alert fatigue. Its ability to wake the deepest of sleepers makes living with diabetes easier and safer. Due to its alerts, unique customization, and the ability to easily track up to two users from anywhere in the world, Sugar Pixel has quickly gained popularity and is now one of the top alert systems recommended to type ones. For more information, check out Sugar Pixel at CustomTypeOne.com.
T1D Exchange is a nonprofit that fosters collaboration and delivers research insights to improve every person’s experience of living with diabetes. We use real-world data and the lived experience of people with type 1 diabetes to improve T1D management and outcomes. The T1D Exchange Registry is our research study in which participants answer a survey once per year. It is open to adults and children with T1D living in the United States. Through our registry, more than 20,000 people with T1D share their experiences and participate in research that drives real change with measurable results. After completing a quick survey, participants get access to an online research dashboard, where they can find opportunities to participate in surveys, clinical trials, at-home studies, and more!
The Diabetes Link’s mission is to empower young adults to thrive. We are the only national non-profit focused on individuals ages 16-30 who are living with diabetes. Our programs include a national peer network on college campuses and online; a free Resource Hub covering the topics most important for young adults; leadership opportunities as college chapter leaders or participation in the The Link Nextgen Fellowship program for those looking to enter the diabetes sector; and resources for allies such as parents, healthcare providers, campus administrators and roommates to better support young adults with diabetes as they transition to adulthood, or to campus. Connect with us: @thediabeteslink or www.thediabeteslink.org.
At 10 years old Elizabeth Forrest was diagnosed with type 1 diabetes and soon after declared diabetes wasn’t going to control her. Inspired by her middle school dance class, she combined her love for dance with her new diagnosis and created Dancing for Diabetes® as a way to bring attention to the millions who are living with Type 1 Diabetes and to raise funds to find a cure. Dancing for Diabetes® became a springboard for additional impactful programs that now make up the Touched by Type 1 organization which include: Dancing for Diabetes®, Kids & Teens with Diabetes Dance program, Type 1 @ School, Touched by Type 1 Annual Conference, Outreach, and the D-Box. Until a cure is found, Touched by Type 1 will continue to elevate awareness of Type 1 Diabetes, raise funds to find a cure, and inspire those with diabetes to thrive.
Transcend provides fast-acting, portable glucose solutions designed for critical blood sugar situations. Our durable, pre-packaged glucose gels and shots ensure rapid response to hypoglycemia and offer reliable and precise glucose level management. Trusted by healthcare professionals, Transcend products are essential for effective, on the-go diabetes care and support in critical moments.
